Another approach is to prevent blood transfusions and thus iron overload by early therapeutic intervention with growth factors (erythropoietin with or without additional granulocyte colony-stimulating factor, G-CSF) or specific targeted drugs. The gene discussed is CSF3; the disease is Tangier disease.